首页 | 本学科首页   官方微博 | 高级检索  
     

结肠癌患者循环miR-630的表达及其临床意义
引用本文:张子茜,李 改,邱 贺,初大可. 结肠癌患者循环miR-630的表达及其临床意义[J]. 现代肿瘤医学, 2020, 0(15): 2649-2652. DOI: 10.3969/j.issn.1672-4992.2020.15.021
作者姓名:张子茜  李 改  邱 贺  初大可
作者单位:西安交通大学第一附属医院消化内科,陕西 西安 710061
基金项目:National Natural Science Foundation of China(No.81672460);国家自然科学基金资助项目(编号:81672460);陕西省创新人才推进计划(编号:2017KJXX-07);陕西省重点研发计划(编号:2019SF-012);陕西省自然科学基础研究计划(编号:2020JM-391)
摘    要:目的:探讨结肠癌患者外周血中microRNA-630(miR-630)的表达,进一步分析其表达对评估结肠癌进展及预后的价值。方法:使用实时荧光定量PCR(Real time PCR)检测55例结肠癌及21例正常对照者外周血中miR-630的表达,采用统计学方法分析miR-630在结肠癌外周血中的表达及其与肿瘤进展和预后的关系。结果:分析Real time PCR检测结果发现,结肠癌患者外周血中miR-630的表达显著高于正常对照(P<0.05),外周血中miR-630表达与结肠癌的侵袭、转移和分期显著相关(P<0.05),单因素和多因素生存分析发现外周血中miR-630的表达上调与结肠癌预后不良显著相关(P<0.05)。结论:结肠癌患者循环miR-630表达显著上调,与结肠癌侵袭和转移密切相关,并可作为结肠癌的独立预后标记分子。

关 键 词:结肠癌  外周血  循环miR-630  进展  预后

Expression and clinical significance of circulating miR-630 in patients with colon cancer
Zhang Zixi,Li Gai,Qiu He,Chu Dake. Expression and clinical significance of circulating miR-630 in patients with colon cancer[J]. Journal of Modern Oncology, 2020, 0(15): 2649-2652. DOI: 10.3969/j.issn.1672-4992.2020.15.021
Authors:Zhang Zixi  Li Gai  Qiu He  Chu Dake
Affiliation:Department of Gastroenterology,the First Affiliated Hospital of Xi'an Jiaotong University,Shaanxi Xi'an 710061,China.
Abstract:Objective:To investigate the expression of microRNA-630(miR-630) in peripheral blood of patients with colon cancer,and to further analyze its value in evaluating the progression and prognosis of colon cancer.Methods:Real-time quantitative PCR was used to detect the expression of miR-630 in peripheral blood of 55 patients with colon cancer and 21 normal controls.The expression of miR-630 in peripheral blood of patients with tumor progression and prognosis was analyzed by appropriate statistical method.Results:The expression of miR-630 in peripheral blood of patients with colon cancer was significantly increased compared with that of normal controls(P<0.05).It was also found to be significantly correlated with tumor invasion,metastasis and TNM stage(P<0.05).Univariate and multivariate survival analysis showed that the up-regulation of miR-630 in peripheral blood was significantly associated with poor prognosis of patients(P<0.05).Conclusion:The expression of circulating microRNA-630 in patients with colon cancer is significantly up-regulated,which is closely related to invasion and metastasis of colon cancer and can be used as an independent prognostic marker for patients with colon cancer.
Keywords:colon cancer   peripheral blood   circulating microRNA-630   progression   prognosis
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号